Niacin/lovastatin
 | |
 | |
| Combination of | |
|---|---|
| Niacin | Lipid-lowering agent |
| Lovastatin | Statin |
| Clinical data | |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| (verify) | |
Niacin/lovastatin (trade names Advicor, Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of the vitamin niacin and the statin drug lovastatin. The combination preparation is marketed by Abbott Laboratories.
It was approved by the FDA on December 17, 2001.
Dosage
The combination is available as tablets containing:[1]
- 500 mg/20 mg
- 750 mg/20 mg
- 1000 mg/20 mg
- 1000 mg/40 mg
References
- ^ "Advicor package insert, How Supplied section". Retrieved 2008-03-15.
External links
- Advicor website
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |